Key result
IV acetazolamide with hyperbaric oxygen reduces experimentally induced syncope by ~64% versus room air.
Why the study?
Does acetazolamide combined with hyperbaric oxygenation prevent experimentally induced syncope in healthy male subjects?
Does acetazolamide combined with hyperbaric oxygenation prevent experimentally induced syncope in healthy male subjects?
Acetazolamide combined with hyperbaric oxygenation significantly reduces the occurrence of experimentally induced syncope in healthy subjects.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for syncope prevention in experimental models; should not change clinical practice.
The protective effects of acetazolamide and hyperbaric oxygenation on experimentally induced syncope were evaluated in seven healthy male subjects. Syncope was induced by vigorous hyperventilation and Valsalva maneuver. Each subject performed these procedures three times in each of the following conditions: (1) breathing room air at normal atmospheric pressure, (2) breathing 100% oxygen at 2.36 atmospheric pressure, (3) breathing 9% oxygen at 2.36 atmospheres and (4) after intravenous injection of 500 mg of acetazolamide while breathing 100% oxygen at 2.36 atmospheres. With comparable changes of arterial pCO 2 and blood pressure during the hyperventilation-Valsalva maneuver, syncope occurred in 19 of 21 (91%) hyperventilation-Valsalva maneuvers performed at ambient environment, in 18 of 21 (86%) when subject was breathing 9% oxygen at 2.36 atmospheres, in 14 of 21 (67%) when 2.36 atmospheres of 100% oxygen was used, and in only 7 of 21 (33%) when acetazolamide was used in conjunction with hyperbaric oxygen. Syncope was completely prevented by hyperbaric oxygenation in one subject and by the combination of acetazolamide and hyperbaric oxygen in four subjects. These studies demonstrate that cerebral vasodilation induced by acetazolamide combined with increased oxygen delivery to the brain resulting from hyperbaric oxygenation may preserve cerebral function during the period of hypotension and hypocapnia produced by hyperventilation and Valsalva maneuver.
No takes yet. Share an insight, caveat, or question.
Kong et al. (1970) studied Experimentally induced syncope (n=7). Acetazolamide and hyperbaric oxygenation vs. Breathing room air at normal atmospheric pressure was evaluated on Occurrence of syncope during hyperventilation-Valsalva maneuver. Intravenous acetazolamide combined with hyperbaric oxygenation reduced the occurrence of experimentally induced syncope to 33% compared to 91% when breathing room air at normal atmospheric pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: